CBSET Logo
Connect with Us
  • Home
  • About CBSET
    • Company
    • Leadership
    • CBSET Mission, Vision & Culture
    • Careers & Internships
    • Facilities & Equipment
    • Education & Training
  • Services
    • Medical Device Testing
    • Drug & Cell-based Therapies
    • Histopathology & Morphometry
    • Auditory Safety & Efficacy Services
    • Physician Training
  • Focus Areas
    • Sympathetic Denervation
    • Coronary Artery Disease (CAD)
    • Peripheral Artery Disease (PAD)
    • Drug-Coated Balloons
    • Thrombectomy & Thrombolysis
    • Bone & Joint Health
    • Oncology
  • Library
    • Scientific Publications and Presentations
    • Brochures & Flyers
  • Newsroom
    • News and Events
    • Event Archives
  • Contact
  • Menu

JSEI 2025: Development of autologous clot models to assess in vivo efficacy and chronic safety of thrombectomy devices

Rami Tsafriri, CBSET’s Director of Research and Innovation, at the 31st Annual Meeting of the Japanese Society for Endovascular Therapy (JSEI) with Drs. Takao Ohki and Terry Hasebe, respectively, the founding and current Presidents of JSEI.


Keynote presentation, 31st Annual Meeting of the Japan Society of Endovascular Therapy (JSEI), June 13-14, Okinawa, Japan

 



Explore Our Services

  • Medical Device Testing
  • Drug & Cell-based Therapies
  • Histopathology & Morphometry
  • Auditory Safety & Efficacy Services
  • Physician Training
Company FAQ

GET IN TOUCH WITH US

CBSET, Inc.
500 Shire Way
Lexington, MA 02421 USA
info@cbset.com
+1 781 541 5555

QUICK LINKS

  • Home
  • Contact CBSET
  • CBSET Services
  • Privacy

FOLLOW US

olaw logo
massmedic logo
massdevice logo
massbio logo
aaalac logo

Copyright CBSET. All rights reserved.